DR. DANIEL J WALLACE M.D. NPI 1982608717

NPI Information

  • NPI: 1982608717
  • Provider Name: DR. DANIEL J WALLACE, M.D.
  • Classification: Internal Medicine - 207RR0500X
  • Specialization: Rheumatology
  • Entity Type: Individual
  • PECOS Registration: Yes
  • Address: 8750 WILSHIRE BLVD STE 210
    BEVERLY HILLS, CA
    ZIP 90211
  • Phone: (310) 652-0920

Map and Directions

Get Directions

NPI Details

DR. Daniel J Wallace, M.D. is a rheumatology internal medicine in Beverly Hills, CA. The provider is an internist who treats diseases of joints, muscle, bones and tendons. This specialist diagnoses and treats arthritis, back pain, muscle strains, common athletic injuries and collagen diseases. DR. Daniel J Wallace, M.D. NPI is 1982608717. The provider is registered as an individual entity type.

The NPPES NPI record indicates the provider is a male.

The provider's business location address is:

8750 WILSHIRE BLVD STE 210
BEVERLY HILLS, CA
ZIP 90211-703
Phone: (310) 652-0920
Fax: (310) 652-2482

The NPI 1982608717 is registered in the Medicare Provider, Enrollment, Chain and Ownership System (PECOS). The provider is legally eligible to order and refer Part B (Clinical Laboratory and Imaging), Durable Medical Equipment, Part A Home Health Agency (HHA), Power Mobility Devices.

The following top HCPCS codes were publicly reported for this provider under the Medicare program for the year 2016. The reported codes are based on the top codes for each available Medicare specialty, excluding evaluation and management codes.

  • Injection, tocilizumab, 1 mg (HCPCS:J3262)
  • Injection, golimumab, 1 mg, for intravenous use (HCPCS:J1602)
  • Injection, belimumab, 10 mg (HCPCS:J0490)
  • Injection, denosumab, 1 mg (HCPCS:J0897)
  • Injection, inclisiran, 1 mg (HCPCS:J1306)
  • Injection, abatacept, 10 mg (code may be used for medicare when drug administered under the direct supervision of a physician, not for use when drug is self administered) (HCPCS:J0129)
  • Established patient office or other outpatient visit, 30-39 minutes (HCPCS:99214)
  • Injection, triamcinolone acetonide, not otherwise specified, 10 mg (HCPCS:J3301)
  • Injection of drug or substance under skin or into muscle (HCPCS:96372)
  • Infusion, normal saline solution, 250 cc (HCPCS:J7050)
  • Measurement of complement (immune system proteins), antigen, (HCPCS:86160)
  • Infusion into a vein for therapy, prevention, or diagnosis, 1 hour or less (HCPCS:96365)
  • Measurement c-reactive protein for detection of infection or inflammation (HCPCS:86140)
  • Red blood cell sedimentation rate, to detect inflammation, non-automated (HCPCS:85651)
  • Gammaglobulin (immune system protein) measurement (HCPCS:82784)
  • Complete blood cell count (red cells, white blood cell, platelets), automated test and automated differential white blood cell count (HCPCS:85025)
  • Blood test, comprehensive group of blood chemicals (HCPCS:80053)
  • Ferritin (blood protein) level (HCPCS:82728)
  • Blood test, thyroid stimulating hormone (tsh) (HCPCS:84443)
  • Vitamin d-3 level (HCPCS:82306)
  • Uric acid level, blood (HCPCS:84550)
  • Blood test, lipids (cholesterol and triglycerides) (HCPCS:80061)
  • Creatine kinase (cardiac enzyme) level, total (HCPCS:82550)
  • Infusion into a vein for therapy, prevention, or diagnosis, each additional hour (HCPCS:96366)
  • Urinalysis, manual test (HCPCS:81002)
  • Iron level (HCPCS:83540)
  • New patient office or other outpatient visit, 45-59 minutes (HCPCS:99204)
  • Hemoglobin a1c level, by device for home use (HCPCS:83037)
  • Administration of chemotherapy into vein, each additional hour (HCPCS:96415)
  • Iron binding capacity (HCPCS:83550)
  • Office or other outpatient visit for the evaluation and management of established patient that may not require presence of healthcare professional (HCPCS:99211)
  • Established patient office or other outpatient visit, 20-29 minutes (HCPCS:99213)
  • Injection, methylprednisolone sodium succinate, up to 125 mg (HCPCS:J2930)
  • Injection of additional new drug or substance into vein (HCPCS:96375)
  • Administration of chemotherapy into vein, 1 hour or less (HCPCS:96413)
  • Thyroxine (thyroid chemical), free (HCPCS:84439)
  • Established patient office or other outpatient visit, 10-19 minutes (HCPCS:99212)
  • Administration of influenza virus vaccine (HCPCS:G0008)
  • Influenza vaccine, quadrivalent derived from cell cultures (HCPCS:90756)
  • Liver enzyme (sgot), level (HCPCS:84450)
  • Blood creatinine level (HCPCS:82565)

The enumeration date for this NPI number is 6/9/2005 and was last updated on 3/22/2022.

Taxonomy Codes

The NPI record includes the healthcare provider taxonomy classification, state license number and state of licensure. The following information regarding the scope of practice of this provider is available:

No. Taxonomy Code Taxonomy Clasification Taxonomy Specialization License Number License State Primary
1207RR0500XInternal MedicineRheumatologyG30533CALIFORNIAYes

Other Identifiers

The following information regarding additional identifiers associated to this NPI record includes the other identifier number, identifier type, identifier state and issuer.

No. Other Provider Identifier Other Provider Identifier Type Other Provider Identifier State Other Provider Identifier Issuer
1PG0080544002OTHERCALIFORNIABLUE SHIELD OF CA
2953744782OTHERCALIFORNIABLUE CROSS

What is NPI?

NPI stands for National Provider Identifier. The NPI is a 10-digit identification number that is completely unique. The NPI number by itself does not contain any identifiable information such as a provider’s speciality or location. The NPI is assigned to individuals or organizacions for their lifespan and it is independent of key provider information type updates like a change of practices, location or speciality.

This page was last updated on: 11/21/2025

NPI Synchronization or Removal

All materials and services on this site are provided on an "as is" and "as available" basis without warranty of any kind. The NPI record is maintained by the National Plan & Provider Enumeration System (NPPES) and anyone may request this information and other NPPES health care provider data from HHS under The Freedom of Information Act (FOIA), Title 5 of the United States Code, section 552. To update the NPI records please contact the NPPES.